Cerus Corp. (NASDAQ:CERS) shares traded up 3% during trading on Tuesday . The stock traded as high as $6.88 and last traded at $6.43, with a volume of 1,923,566 shares changing hands. The stock had previously closed at $6.24.

Several research analysts have commented on the company. FBR & Co reissued a “buy” rating on shares of Cerus Corp. in a research report on Monday, July 11th. BTIG Research reissued a “buy” rating and issued a $10.00 price objective on shares of Cerus Corp. in a research report on Monday, June 20th. Robert W. Baird reissued an “outperform” rating and issued a $9.00 price objective on shares of Cerus Corp. in a research report on Wednesday, June 22nd. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $9.00 price objective on shares of Cerus Corp. in a research report on Thursday, July 7th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $8.90.

The firm’s market cap is $649.93 million. The stock has a 50 day moving average price of $6.07 and a 200 day moving average price of $5.80.

Cerus Corp. (NASDAQ:CERS) last announced its earnings results on Tuesday, May 3rd. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by $0.01. During the same quarter in the prior year, the business posted ($0.17) earnings per share. The business had revenue of $7.60 million for the quarter, compared to the consensus estimate of $8.29 million. The firm’s revenue for the quarter was down 1.3% on a year-over-year basis. On average, equities research analysts predict that Cerus Corp. will post ($0.65) EPS for the current year.

Other institutional investors recently bought and sold shares of the company. California State Teachers Retirement System boosted its position in Cerus Corp. by 1.8% in the fourth quarter. California State Teachers Retirement System now owns 176,709 shares of the company’s stock valued at $1,117,000 after buying an additional 3,126 shares in the last quarter. EAM Investors LLC bought a new position in Cerus Corp. during the fourth quarter valued at approximately $1,139,000. Rail Splitter Capital Management LLC boosted its position in Cerus Corp. by 19.0% in the fourth quarter. Rail Splitter Capital Management LLC now owns 832,722 shares of the company’s stock valued at $5,263,000 after buying an additional 132,970 shares in the last quarter. Stephens Inc. AR boosted its position in Cerus Corp. by 11.3% in the fourth quarter. Stephens Inc. AR now owns 1,112,665 shares of the company’s stock valued at $7,032,000 after buying an additional 113,238 shares in the last quarter. Finally, Wells Fargo & Company MN boosted its position in Cerus Corp. by 25.9% in the fourth quarter. Wells Fargo & Company MN now owns 4,901,666 shares of the company’s stock valued at $30,979,000 after buying an additional 1,007,430 shares in the last quarter.

Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company’s INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.